On 08 May 2019
Vivimed Labs announced that its Board has decided to sell its stake in 50:50 JV with Strides for augmenting management focus on the growing FDF portfolio across India, RoW and CISmarkets and also to Improve financial flexibility for the domestic finished dosage business and reduction of long term leverage in the Indian operations. Consequently, VLL Sold balance 50% stake in Vivimed Life Sciences Private Limited, India to Strides Pharma Science Limited and the balance 50% stake in Strides Vivimed Pte Ltd, Singapore to Strides Pharma Global Pte, Singapore.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)